We are live on ! Find out more

7 hedge funds and large institutions have $6.43M invested in iHuman in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 7 → 7 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

1.28% less ownership

Funds ownership: 6.22% → 4.94% (-1.3%)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

96% less capital inflows, than outflows

Capital inflows: $52.6K | Capital outflows: $1.46M

Holders
7
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
1
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

IH Hedge Fund Activity: Q4 2022 in Review

7 of the 6,245 institutional investors tracked by Wall St. Rank reported a position in iHuman (IH) for Q4 2022, worth a combined $6.43M — down 12% from $7.29M a quarter earlier.

Fund positioning in IH was balanced in Q4 2022: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 3 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $25.4K. The largest seller was Morgan Stanley, cutting an estimated $1.14M.

  • 7 institutional investors held iHuman (IH) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $6.43M of iHuman stock for Q4 2022, down 12% quarter-over-quarter.
  • 2 funds opened new iHuman positions in Q4 2022 and 2 closed out, a net change of 0 holders.
  • The largest iHuman buyer in Q4 2022 was Renaissance Technologies, an estimated $25.4K added.
  • The largest iHuman seller in Q4 2022 was Morgan Stanley, an estimated $1.14M sold.

Based on aggregated 13F filings for Q4 2022.